7th International Symposium on Malignant Pleural Mesothelioma
UCLA Meyer & Renee Luskin
Conference Center
Los Angeles, California
September 30, 2017
Download: [ PDF ]
Malignant pleural mesothelioma (MPM) is an unusual cancer because it grows throughout the chest cavity as a diffuse process rather than a typical solid nodule or mass. Because of this unique characteristic, it has very specific treatment issues. MPM also is a rare tumor with less than 3,000 new cases annually, and therefore, most physicians, even pulmonologists and medical oncologists, typically only see these patients infrequently. Despite this, it is critical that all physicians involved in the care of MPM patients be familiar with the important issues in this disease and possess a thorough understanding regarding the tumor itself, its evaluation process, staging, treatment and the role of multidisciplinary management of these patients. This includes the role and extent of surgery as well as radiation, chemotherapy and newer targeted therapies and immunotherapy. Robert B. Cameron, MD, the course organizer and the Director of the UCLA Comprehensive Mesothelioma Program, has had over 30 years of experience with treating patients with MPM, including pleurectomy and decortication surgical procedures and a number of complementary adjuvant therapies with the goal of treating this deadly disease like a chronic illness, similar to hypertension and diabetes.
Target Audience
- Pulmonary physicians who are frequently involved in patient workups
- Medical oncologists who are frequently involved in patient therapy
- Mesothelioma experts who want to learn/share experiences about lung-sparing therapies
- Patients, family and friends who desire to learn more about the disease
Enrollment
To enroll click here.
By Mail
Send the completed enrollment form to:
David Geffen School of Medicine at UCLA
Office of Continuing Medical Education
7th International Symposium on Malignant Pleural Mesothelioma
10920 Wilshire Blvd., Suite 1060
Los Angeles, CA 90024-6512
By FAX
Fax the enrollment form with charge card information and your authorizing signature to (310) 794-2624.
By Phone
Use your American Express, MasterCard, VISA, or Discover card. Call (310) 794-2620
Registration Fee
Pre-registration fee (before September 6):
- $150.00 - Physicians
- $100.00 - Nurses
- $75.00 - Family Members & Patients
- $25.00 - Students*
- $400.00 - Legal Profession
Late registration fee (starting September 6):
- $225.00 - Physicians
- $150.00 - Nurses
- $100.00 - Family Members & Patients
- $40.00 - Students*
- $650.00 - Legal Profession
*must show student ID on-site
Refunds
Cancellations must be received in writing by September 1, 2017 and will be subject to a $75 processing fee. A full refund will be provided if for any reason the course must be cancelled or rescheduled.
Course Chair
Robert B. Cameron, MD, FACS
Professor of Clinical Cardiothoracic Surgery and Surgical Oncology
Director, Comprehensive Mesothelioma Program
David Geffen School of Medicine at UCLA
Chief, Thoracic Surgery
West Los Angeles VA Medical Center
Los Angeles, California
International and Distinguished Faculty
Luana Calabrò, MD
Center for Immuno-Oncology
University Hospital of Siena
Siena, Italy
Brian Cunniff, PhD
Faculty Scientist
Department of Pathology
Vermont Cancer Center
University of Vermont College of Medicine
Burlington, Vermont
Jacques P. Fontaine, MD
Thoracic Surgeon
Associate Professor - University of South Florida
Moffitt Cancer Center
Tampa, Florida
Anna K. Nowak, MBBS, FRACP, PhD
Professor, Faculty of Medicine
University of Western Australia
Western Australia, Australia
Arti Shukla, PhD
Associate Professor
Departments of Pathology and Medicine
Larner College of Medicine
University of Vermont
Burlington, Vermont
David S. Schrump, MD, MBA, FACS
Senior Investigator and Chief
Thoracic and GI Oncology Branch
Center for Cancer Research
National Cancer Institute
Bethesda, Maryland
Haining Yang, MD, PhD
Professor
Cancer Biology Program
University of Hawaii Cancer Center
Honolulu, Hawaii
Faculty
Clare Cameron, BA
Executive Director
Pacific Mesothelioma Center
Pacific Heart, Lung, & Blood Institute
Los Angeles, California
Lien Hua-Feng, RN, MSN, NP-C
Nurse Practitioner
Pacific Mesothelioma Center
Pacific Heart, Lung, & Blood Institute
Los Angeles, California
Olga Olevsky, MD
Health Sciences Assistant Clinical Professor
Santa Monica Oncology
David Geffen School of Medicine at UCLA
Santa Monica, California
Saturday, September 30, 2017 |
|
| 7:30 | Registration and Breakfast |
| 8:00 |
Welcome Robert B. Cameron, MD, FACS |
|
Morning Session I Moderator: Robert B. Cameron, MD, FACS |
|
| 8:15 |
Surgery for Mesothelioma: Is There a Future? Robert B. Cameron, MD, FACS |
| 8:45 |
Intracavitary Therapeutics for Pleural Malignancies Olga Olevsky, MD |
| 9:15 |
Transarterial Chemoperfusion Jacques P. Fontaine, MD |
| 9:45 | Discussion |
| 10:15 | Break |
|
Morning Session II Moderator: Olga Olevsky, MD |
|
| 10:30 |
Immune Checkpoint Blockade in Malignant Mesothelioma Luana Calabrò, MD |
| 11:00 |
Combining Angiogenesis Inhibition with Chemotherapy - Who, How and What's Next? Anna K. Nowak, MBBS, FRACP, PhD |
| 11:30 |
Recent Findings on Mesothelioma and BAP1 Haining Yang, MD, PhD |
| 12:00 | Discussion |
| 12:30 | Lunch |
|
Afternoon Session I Moderators: Robert B. Cameron, MD, FACS |
|
| 1:30 |
The Potato in the Tailpipe! Disabling Mitochondrial Peroxide Metabolism as an Effective Therapeutic Approach for MPM Brian Cunniff, PhD |
| 2:00 |
Targeting the Epigenome in Malignant Pleural Mesothelioma David S. Schrump, MD, MBA, FACS |
| 2:30 |
Engineering Mesenchymal Stem Cells for Immunotherapy of Mesothelioma Robert B. Cameron, MD, FACS |
| 3:00 |
Inflammasome Modulation by Chemotherapeutics in Mesothelioma: Is This a New Possibility? Arti Shukla, PhD |
| 3:30 | Discussion |
| 4:00 | Break |
|
Afternoon II Moderators: Robert B. Cameron, MD, FACS |
|
| 4:15 |
The Benefits of a Mesothelioma Caregiver Support Group Lien Hua-Feng, RN, MSN, NP-C |
| 4:30 |
Resources for Research - Student Internship Program Clare Cameron, BA |
| 4:45 | Discussion |
| 4:55 |
Concluding Remarks Robert B. Cameron, MD, FACS |
| 5:00 | Adjourn |
At the completion of this course, participants should be able to:
- Describe the current role of each traditional modality in multidisciplinary therapies, including surgery, radiation, and chemotherapy
- Name the possibilities for intraoperative adjuvant therapies
- Review the nature of MPM and the need for chronic treatment
- Cite the various types of biological and immunological therapies and their potential role in therapy
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Office of Continuing Medical Education, David Geffen School of Medicine at UCLA designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
The FDA has issued a concept paper which classifies commercial support of scientific and educational programs as promotional unless it can be affirmed that the program is "truly independent" and free of commercial influence. In addition to independence, the FDA requires that nonpromotional, commercially supported education be objective, balanced, and scientifically rigorous. The policy further states that all potential conflicts of interest of the CME staff and faculty be fully disclosed to the program's participants. In addition, Accreditation Council for Continuing Medical Education policy now mandates that the provider adequately manages all identified potential conflicts of interest prior to the program. We at UCLA fully endorse the letter and spirit of these concepts.
Location
UCLA Meyer & Renee Luskin Conference Center
425 Westwood Plaza
Los Angeles, CA 90095
855-522-8252
Local Accommodations
Please note there are no room blocks reserved at any location. Any special rates are subject to change and subject to availability.
UCLA Meyer & Renee Luskin Conference Center
855-522-8252
Palomar Hotel
310-475-8711 (Ask for the UCLA rate)
The Beverly Hilton
310-274-7777 (Ask for the UCLA rate)
Parking
Self-Parking $12
Valet Parking is reserved only for overnight guests at the Conference Center.
Directions
From the 405 freeway, exit Wilshire Blvd., east toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. Pay per license plate at the kiosk and display the parking permit on your dash.